In chronic GVHD, mBreg cells can provide protection by the suppressive effects and inhibit proliferation of effector T cells through IL‐10 secretion and cell‐to‐cell contact involving CTLA-4. The gene discussed is CTLA4; the disease is chronic graft versus host disease.